Search clinical trials for: MEDI4920

Total 7 results

MedImmune LLC

Completed

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

Healthy Volunteer

United Kingdom
Viela Bio

Completed

A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis

Adult Onset Rheumatoid Arthritis

United States, Poland
Viela Bio (acquired by Horizon Therapeutics)

Completed

A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis (MIDORA)

Rheumatoid Arthritis

United States, Poland
Amgen

Recruiting

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Sjögren's Syndrome (SS)

United States
Viela Bio (acquired by Horizon Therapeutics)

Completed

A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Kidney Transplantation | Transplant Rejection | Allografts | Rejection; Transplant, Kidney

United States
Amgen

Recruiting

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Sjogren's Syndrome

Israel, Chile, United States, Argentina, Canada, Japan, Korea, Republic of
Amgen

Completed

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome

United States, France, Italy, Hungary, Poland, Argentina, India, Korea, Republic of, Mexico, Peru, Taiwan, United Kingdom

3

Subscribe